小结
定义
病史和体格检查
关键诊断因素
- presença de fatores de risco
- exposição ao fogo com inalação de fumaça
- náuseas
- cefaleia
- vômitos
- visão turva
- tontura
- vertigem
- alteração do nível de consciência
- dispneia
- taquicardia
- hipotensão ou hipertensão
- arritmia cardíaca
- dor
- fraqueza
- alterações no sono
- irritabilidade
- sintomas influenza-símiles
其他诊断因素
- características neuropsiquiátricas tardias
- outros sintomas neurológicos graves
- bolhas cutâneas
- edema pulmonar
- exposição ao cloreto de metileno
- parada cardíaca
- anormalidades neurológicas focais (por exemplo, hemiplegia, ataxia troncular)
- coagulação intravascular disseminada
危险因素
- exposição à combustão incompleta de material contendo carbono
- exposição ao fogo com inalação de fumaça
- exposição ao cloreto de metileno
诊断性检查
首要检查
- nível de carboxi-hemoglobina
- Eletrocardiograma (ECG)
- monitoramento cardíaco
- glicose sanguínea
- hemograma completo
- ureia e eletrólitos
- creatinina
- lactato
- nível de pH
- biomarcadores cardíacos
- creatina quinase
需考虑的检查
- radiografia torácica
- Miniexame do Estado Mental
- tomografia computadorizada (TC) do crânio
- imagem e espectroscopia por ressonância nuclear magnética
- testes da função hepática
- teste de gravidez
治疗流程
todos os pacientes
撰稿人
作者
Richard Moon, MD
Professor of Anesthesiology
Professor of Medicine
Division of Pulmonary, Allergy and Critical Care Medicine
Duke University
Durham
NC
利益声明
RM has been reimbursed by Merck for contributions to the Merck Manual.
鸣谢
Dr. Richard Moon would like to gratefully acknowledge Dr Jason Rose and Dr Prasanthi Govindarajan, previous contributors to this topic. PG declares that she has no competing interests. JR is a co-inventor on patent applications for the use of heme-based molecules as antidotes for CO poisoning. JR is a shareholder, officer, and director of Globin Solutions, Inc. Globin Solutions, Inc. has an exclusive license to this technology. Globin Solutions, Inc. had an option agreement to technology directed at using hydroxycobalamin for CO poisoning from Virginia Commonwealth University in the last 12 months. JR is an author of publications cited within this topic.
同行评议者
Richard S. Weisman, PharmD
Director
Florida Poison Center
Miami
FL
利益声明
RSW declares that he has no competing interests.
Sean Patrick Nordt, MD, PharmD
Resident Physician
Department of Emergency Medicine
University of California
San Diego
CA
利益声明
SPN declares that he has no competing interests.
Paul Hamilton, MD
Director
Department of Emergency Medicine
Mount Sinai School of Medicine
New York
NY
利益声明
PH declares that he has no competing interests.
Ruben Thanacoody, MD, FRCP(Edin)
Consultant Physician and Clinical Toxicologist
Regional Drugs and Therapeutics Centre
Newcastle-upon-Tyne
UK
利益声明
RT declares that he has no competing interests.
鉴别诊断
- Infecção viral
- Intoxicação alcoólica
- Enxaqueca
更多 鉴别诊断指南
- Clinical guidance for carbon monoxide (CO) poisoning
- Carbon monoxide: incident management
更多 指南患者教育信息
Intoxicação por monóxido de carbono
更多 患者教育信息登录或订阅即可浏览 BMJ Best Practice 临床实践完整内容
内容使用需遵循免责声明